National Health Investors, Inc. Stock

Equities

NHI

US63633D1046

Specialized REITs

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
61.52 USD +1.79% Intraday chart for National Health Investors, Inc. +5.31% +10.15%
Sales 2024 * 320M Sales 2025 * 352M Capitalization 2.62B
Net income 2024 * 123M Net income 2025 * 134M EV / Sales 2024 * 12.2 x
Net Debt 2024 * 1.29B Net Debt 2025 * 1.32B EV / Sales 2025 * 11.2 x
P/E ratio 2024 *
21.3 x
P/E ratio 2025 *
20.1 x
Employees 27
Yield 2024 *
5.99%
Yield 2025 *
6.07%
Free-Float 95.38%
More Fundamentals * Assessed data
Dynamic Chart
Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting CI
Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating MT
North American Morning Briefing : Stock Futures -2- DJ
BMO Capital Upgrades National Health Investors to Outperform From Market Perform MT
National Health Investors Insider Bought Shares Worth $586,882, According to a Recent SEC Filing MT
North American Morning Briefing : Stock Futures -2- DJ
National Health Investors Shares Rise After Wells Fargo, Wedbush Upgrade MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Price Target is $63 MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Adjusts Price Target to $63 From $55 MT
Wedbush Upgrades National Health Investors to Outperform From Neutral, Says More Optimistic on Skilled Nursing Facilities/Senior Housing; Raises PT to $64 From $57 MT
Transcript : National Health Investors, Inc., Q4 2023 Earnings Call, Feb 21, 2024
National Health Investors' Q4 Normalized FFO, Revenue Rise; 2024 Outlook Issued MT
Earnings Flash (NHI) NATIONAL HEALTH INVESTORS Reports Q4 Revenue $79.5M MT
National Health Investors, Inc. Provides Earnings Guidance for the Year 2024 CI
National Health Investors, Inc. Announces First Quarter Dividend, Payable on May 3, 2024 CI
More news

Latest transcript on National Health Investors, Inc.

1 day+1.79%
1 week+5.31%
Current month-2.08%
1 month+0.31%
3 months+11.85%
6 months+25.27%
Current year+10.15%
More quotes
1 week
57.95
Extreme 57.95
61.69
1 month
57.80
Extreme 57.8
62.93
Current year
51.59
Extreme 51.59
62.93
1 year
47.54
Extreme 47.54
62.93
3 years
47.54
Extreme 47.54
74.95
5 years
31.37
Extreme 31.37
91.12
10 years
31.37
Extreme 31.37
91.12
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 15-01-25
Founder 78 90-12-31
Director of Finance/CFO 64 16-03-07
Members of the board TitleAgeSince
Director/Board Member 77 20-05-05
Founder 78 90-12-31
Director/Board Member 79 90-12-31
More insiders
Date Price Change Volume
24-04-19 61.52 +1.79% 213,432
24-04-18 60.44 +1.49% 167,921
24-04-17 59.55 +1.26% 226,095
24-04-16 58.81 -0.41% 116,171
24-04-15 59.05 +1.08% 125,995

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
National Health Investors, Inc. is a real estate investment trust. The Company specializes in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and lease, mortgage, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has 163 healthcare real estate properties located in 31 states and leased primarily pursuant to triple-net leases to 25 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The SHOP segment has 15 properties located in eight states with a combined 1,733 units.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
60.44 USD
Average target price
62.83 USD
Spread / Average Target
+3.96%
Consensus